Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 6, 2008
Grant Date -
Oct 20, 2005
app pub date -
Feb 28, 2005
filing date -
Aug 26, 1992
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Peptides are used to define epitopes that stimulate HLA-restricted cytotoxic T lymphocyte activity against hepatitis B virus antigens. The peptides are derived from regions of HBV envelope, and are particularly useful in treating or preventing HBV infection, including methods for stimulating the immune response of chronically infected individuals to respond to HBV antigens.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully